nach oben

Neurological Sciences

Erschienen in:

01.05.2009 | ANIRCEF – HCNE Joint Meeting

Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications

verfasst von: S. M. Baskin, Todd A. Smitherman

Erschienen in: Neurological Sciences | Sonderheft 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Migraine is often comorbid with psychiatric disorders such as major depression, bipolar disorder, and anxiety disorders. Although most of the research on psychiatric comorbidities and migraine is of an epidemiologic nature, a growing body of literature has investigated possible mechanisms underlying this relationship, such as medication overuse, serotonergic dysfunction, ovarian hormone fluctuations, and central sensitization. The present article overviews this growing literature and notes strategies for the clinical management of migraine patients with psychiatric comorbidities.

Baskin SM, Lipchik GL, Smitherman TA (2006) Mood and anxiety disorders in chronic headache. Headache 46(Suppl 3):S76–S87PubMedCrossRef

Radat F, Swendsen J (2004) Psychiatric comorbidity in migraine: a review. Cephalalgia 25:165–178CrossRef

Lake AE, Rains JC, Penzien DB, Lipchik GL (2005) Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance. Headache 45:493–506PubMedCrossRef

Hamelsky SW, Lipton RB (2006) Psychiatric comorbidity of migraine. Headache 46:1327–1333PubMed

Breslau N (1998) Psychiatric comorbidity in migraine. Cephalalgia 18(Suppl 22):56–61PubMed

Feinstein A (1970) The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis 23:455–468CrossRef

Bigal ME, Lipton RB (2006) Modifiable risk factors for migraine progression. Headache 46:1334–1343PubMedCrossRef

Scher AI, Midgette LA, Lipton RB (2008) Risk factors for headache chronification. Headache 48:16–25PubMed

Smitherman TA, Penzien DB, Maizels M (2008) Anxiety disorders and migraine intractability and progression. Curr Pain Headache Rep 12:224–229PubMedCrossRef

10.

Guidetti V, Galli F, Fabrizi P, Giannantoni AS, Napoli L, Bruni O, Trillo S (1998) Headache and psychiatric comorbidity: clinical aspects and outcome in a 8-year follow-up study. Cephalalgia 18:455–462PubMedCrossRef

11.

Pesa J, Lage MJ (2004) The medical costs of migraine and comorbid anxiety and depression. Headache 44:562–570PubMedCrossRef

12.

Lanteri-Minet M, Radat F, Chautard MH, Lucas C (2005) Anxiety and depression associated with migraine: influence on migraine subjects’ disability and quality of life, and acute migraine management. Pain 118:319–326PubMedCrossRef

13.

Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM (2000) Headache and major depression: is the association specific to migraine? Neurology 54:308–313PubMed

14.

Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM (2003) Comorbidity of migraine and depression. Neurology 60:1308–1312PubMed

15.

Breslau N, Schultz LR, Stewart WF, Lipton R, Welch KM (2001) Headache types and panic disorder: directionality and specificity. Neurology 56:350–354PubMed

16.

Breslau N, Davis GC, Andreski P (1991) Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 137:11–23CrossRef

17.

McWilliams LA, Goodwin RD, Cox BJ (2004) Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 111:77–83PubMedCrossRef

18.

Patel NV, Bigal ME, Kolodner KB et al (2004) Prevalence and impact of migraine and probable migraine in a health plan. Neurology 63:1432–1438PubMed

19.

Fasmer OB, Oedegaard KJ (2001) Clinical characteristics of patients with major affective disorders and comorbid migraine. World J Biol Psychiatry 2:149–155PubMedCrossRef

20.

Oedegaard KJ, Angst J, Neckelmann D, Fasmer OB (2005) Migraine aura without headache compared to migraine with aura in patients with affective disorders. J Headache Pain 6:378–386PubMedCrossRef

21.

Oedegaard KJ, Neckelmann D, Mykletun A et al (2006) Migraine with and without aura: association with depression and anxiety disorder in a population-based study. The Hunt Study. Cephalalgia 26:1–6PubMedCrossRef

22.

Merikangas KR, Angst J, Isler H (1990) Migraine and psychopathology. Arch Gen Psychiatry 47:849–853PubMed

23.

Merikangas KR, Merikangas JR, Angst J (1993) Headache syndromes and psychiatric disorders: association and familial transmission. J Psychiatr Res 27:197–210PubMedCrossRef

24.

Oedegaard KJ, Fasmer OB (2005) Is migraine in unipolar depressed patients a bipolar spectrum trait? J Affect Disorders 84:233–242PubMedCrossRef

25.

Swartz KL, Pratt LA, Armenian HK, Lee LC, Eaton WW (2000) Mental disorders and the incidence of migraine headaches in a community sample: results from the Baltimore Epidemiologic Catchment area follow-up study. Arch Gen Psychiatry 57:945–950PubMedCrossRef

26.

Evans RW, Rosen N (2008) Migraine, psychiatric comorbidities and treatment. Headache 48:952–958PubMedCrossRef

27.

de Leeuw R, Schmidt JE, Carlson CR (2005) Traumatic stressors and post-traumatic stress disorder symptoms in headache patients. Headache 45:1365–1374PubMed

28.

Peterlin BL, Tietgen G, Meng S, Lidicker J, Bigal M (2008) Post-traumatic stress disorder in episodic and chronic migraine. Headache 48:517–522PubMedCrossRef

29.

Tietgen GE, Brandes JL, Digre KB et al (2007) History of childhood maltreatment is associated with comorbid depression in women with migraine. Neurology 69:959–968CrossRef

30.

Peterlin BL, Ward TW, Lidicker J, Levin M (2007) A retrospective, comparative study on the frequency of abuse in migraine and chronic daily headache. Headache 47:397–401PubMed

31.

Tietjen GE, Herial NA, Hardgrove J, Utley C, White L (2007) Migraine comorbidity constellations. Headache 47:857–865PubMedCrossRef

32.

Maizels M, Smitherman TA, Penzien DB (2006) A review of screening tools for psychiatric comorbidity in headache patients. Headache 46(Suppl 3):S98–S109PubMedCrossRef

33.

Verri AP, Proietti Cecchini A, Galli C, Granella F, Sandrini G, Nappi G (1998) Psychiatric comorbidity in chronic daily headache. Cephalalgia 18(Suppl 21):45–49PubMed

34.

Zwart JA, Dyb G, Hagen K, Odegard KJ, Dahl AA, Bovim G, Stovner LJ (2003) Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study. Eur J Neurol 10:147–152PubMedCrossRef

35.

Juang KD, Wang SJ, Fuh JL, Lu SR, Su TP (2000) Comorbidity of depressive and anxiety disorder in chronic daily headache and its subtypes. Headache 40:818–823PubMedCrossRef

36.

Atasoy HT, Atasoy N, Unal AE, Emre U, Sumer M (2005) Psychiatric comorbidity in medication overuse headache patients with preexisting headache type of episodic tension type headache. Eur J Pain 9:285–291PubMedCrossRef

37.

Radat F, Creac’h C, Swendsen JD et al (2005) Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 25:519–522PubMedCrossRef

38.

Radat F, Sakh D, Lutz G et al (1999) Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs. Headache 39:477–480PubMedCrossRef

39.

Lake AE (2006) Medication overuse headache: Biobehavioral issues and solutions. Headache 46(Suppl 3):S88–S97PubMedCrossRef

40.

Rothrock J, Lopez I, Zweilfer R et al (2007) Borderline personality disorder and migraine. Headache 47:22–26PubMed

41.

Rot M, Mathew SJ, Charney DS (2009) Neurobiological mechanisms in major depressive disorder. CMAJ 180:305–313

42.

Lotrich FE, Pollock BG (2004) Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr Gen 14:121–129CrossRef

43.

Caspi A, Sugden K, Moffitt TE et al (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386–389PubMedCrossRef

44.

Lesch KP, Bengel D, Heils A et al (1996) Association of anxiety-related traits with polymorphisms in the serotonin transporter gene regulatory region. Science 274:1527–1531PubMedCrossRef

45.

Sen S, Burmeister M, Ghosh D (2004) Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 127:85–89CrossRef

46.

Juhasz G, Zsombok T, Laszik A, Gonda X, Sotonyi P, Faludi G, Bagdy G (2003) Association analysis of 5-HTTLPR variants, 5-HT2a receptor gene 102T/C polymorphism and migraine. J Neurogenet 17:231–240PubMed

47.

Todt U, Freudenberg J, Goebel I et al (2006) Variation of the serotonin receptor gene SLC6A4 in the susceptibility to migraine with aura. Neurology 67:1707–1709PubMedCrossRef

48.

Marziniak M, Mossner R, Schmitt A, Lesch KP, Sommer C (2005) A functional serotonin transporter gene polymorphism is associated with migraine with aura. Neurology 64:157–159PubMed

49.

Kotani K, Shimomura T, Shimomura F, Ikawa S, Nanba E (2002) A polymorphism in the serotonin transporter gene regulatory region and frequency of migraine attacks. Headache 42:893–895PubMedCrossRef

50.

Hamel E (2007) Serotonin and migraine: biology and clinical implications. Cephalalgia 27:1295–1300CrossRef

51.

Ferrari MD, Saxena PR (1993) On serotonin and migraine: a clinical and pharmacological review. Cephalalgia 13:151–165PubMedCrossRef

52.

Martin VT, Behbehani M (2006) Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis-part I. Headache 46:3–23PubMedCrossRef

53.

Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41:646–657PubMedCrossRef

54.

Kessler RC, McGonagle KA, Zhao S et al (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorder in the United States. Results from the National Comorbidity Survey. Arch Gen Psych 51:8–19

55.

Monroe SM, Harkness KL (2005) Life stress, the “kindling” hypothesis, and the recurrence of depression: considerations from a life stress perspective. Psychol Rev 112:417–445PubMedCrossRef

56.

Welch KMA, Nagesh V, Aurora SK, Gelman N (2001) Periaqujeductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41:629–637PubMedCrossRef

57.

Videbech P, Ravnkilde B (2004) Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 161:1957–1966PubMedCrossRef

58.

Barden N (2004) Implication of the hypothalamic–pituitary–adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 29:185–193PubMed

59.

Peres MF, Sanchez DR, Seabra ML et al (2001) Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry 71:747–751PubMedCrossRef

60.

Bigal ME, Lipton RB, Holland PR, Goadsby PJ (2007) Obesity, migraine and chronic migraine: possible mechanisms of interaction. Neurology 68:1851–1861PubMedCrossRef

61.

Miura H, Ozaki N, Sawada M et al (2008) A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 11:198–209PubMedCrossRef

62.

Lipchik GL, Smitherman TA, Penzien DB, Holroyd KA (2006) Basic principles and techniques of cognitive-behavioral therapies for comorbid psychiatric symptoms among headache patients. Headache 46(Suppl 3):S119–S132PubMedCrossRef

63.

Griffith JL, Razavi M (2006) Pharmacological management of mood and anxiety disorders in headache patients. Headache 46(Suppl 3):S133–S141PubMedCrossRef

64.

Silberstein S, Dodick D, Freitag F et al (2007) Pharmacological approaches to managing migraine and associated comorbidities: clinical considerations for monotherapy versus polytherapy. Headache 47:585–599PubMed

65.

Huffman JC, Stern TA (2007) Neuropsychiatric consequences of cardiovascular medications. Dialogues Clin Neurosci 9:29–45PubMed

66.

Belmaker RH (2004) Bipolar disorder. N Engl J Med 351:476–486PubMedCrossRef

67.

Shapiro RE, Tepper SJ (2007) The serotonin syndrome, triptans, and the potential for drug–drug interactions. Headache 47:266–269PubMedCrossRef

68.

Thase ME (1999) Long-term nature of depression. J Clin Psychiatry 60(Suppl 14):3–9

69.

Qaseem A, Snow V, Denberg TD et al (2008) Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. Ann Int Med 149:725–733PubMed

70.

Prien RF, Kupfer DJ (1986) Continuation drug therapy for major depressive episodes: how long should it be maintained? Am J Psychiatry 143:18–23PubMed

71.

Pampallona S, Bollini P, Tibaldki G et al (2004) Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiatry 61:714–719PubMedCrossRef

Titel: Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications
verfasst von: S. M. Baskin
Todd A. Smitherman
Publikationsdatum: 01.05.2009
Verlag: Springer Milan
Erschienen in: Neurological Sciences / Ausgabe Sonderheft 1/2009
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-009-0071-5

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2009

Alterations in the cerebral venous circulation as a cause of headache

Clinical features and outcomes in spontaneous intracranial hypotension: a survey of 90 consecutive patients

Antimigraine drugs: new frontiers

Migraine prevalence in eating disorders and pathophysiological correlations

Cluster headache and TACs: rationale for central and peripheral neuromodulation